- Home
- SLGL vs NXGL Comparison
SLGL vs NXGL Comparison
Compare SLGL & NXGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLGL
- NXGL
- Stock Information
- Founded
- SLGL 1997
- NXGL 1997
- Country
- SLGL Israel
- NXGL United States
- Employees
- SLGL N/A
- NXGL N/A
- Industry
- SLGL Biotechnology: Pharmaceutical Preparations
- NXGL Medical/Dental Instruments
- Sector
- SLGL Health Care
- NXGL Health Care
- Exchange
- SLGL Nasdaq
- NXGL Nasdaq
- Market Cap
- SLGL 19.3M
- NXGL 19.7M
- IPO Year
- SLGL 2018
- NXGL 2021
- Fundamental
- Price
- SLGL $7.26
- NXGL $2.49
- Analyst Decision
- SLGL Buy
- NXGL
- Analyst Count
- SLGL 1
- NXGL 0
- Target Price
- SLGL $40.00
- NXGL N/A
- AVG Volume (30 Days)
- SLGL 25.3K
- NXGL 44.0K
- Earning Date
- SLGL 08-15-2025
- NXGL 08-13-2025
- Dividend Yield
- SLGL N/A
- NXGL N/A
- EPS Growth
- SLGL N/A
- NXGL N/A
- EPS
- SLGL N/A
- NXGL N/A
- Revenue
- SLGL $12,103,000.00
- NXGL $10,228,000.00
- Revenue This Year
- SLGL N/A
- NXGL $52.35
- Revenue Next Year
- SLGL $31.17
- NXGL $42.38
- P/E Ratio
- SLGL N/A
- NXGL N/A
- Revenue Growth
- SLGL 603.66
- NXGL 116.01
- 52 Week Low
- SLGL $3.34
- NXGL $1.95
- 52 Week High
- SLGL $16.50
- NXGL $5.10
- Technical
- Relative Strength Index (RSI)
- SLGL 52.97
- NXGL 50.64
- Support Level
- SLGL $7.02
- NXGL $2.31
- Resistance Level
- SLGL $7.58
- NXGL $2.55
- Average True Range (ATR)
- SLGL 0.37
- NXGL 0.21
- MACD
- SLGL 0.02
- NXGL 0.01
- Stochastic Oscillator
- SLGL 41.28
- NXGL 44.52
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.